Cargando…
Best Pharmaceuticals for Children: How Far Have We Come?
Autores principales: | Mazer-Amirshahi, Maryann, van den Anker, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008771/ https://www.ncbi.nlm.nih.gov/pubmed/25067983 http://dx.doi.org/10.1016/j.curtheres.2013.05.001 |
Ejemplares similares
-
Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011) -
Understanding Bioluminescence in Dinoflagellates—How Far Have We Come?
por: Valiadi, Martha, et al.
Publicado: (2013) -
Candida glabrata Biofilms: How Far Have We Come?
por: Rodrigues, Célia F., et al.
Publicado: (2017)